Data may be out of date. Our scheduled checks are behind: the last successful check of the sources finished 20 Oct 2026, 21:00 UTC (13 days ago), more than 36 hours ago. Checks normally run twice daily, so figures on this page may be out of date. See the service status.
ShortageSignal

← All medicines

Medicine · bench card

Premique Low Dose

As of 03 Nov 2026 00:45 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.

Latest England noticeMSN/2021/071 Tier 2 · issued 22 Dec 2021 (1777 days ago)
Expected backw/c 10th January 2022 as stated in the latest recorded notice stated date passed — no update recorded (1752 days)window end 16 Jan 2022, derived from “w/c 10th January 2022”
Protocolno Serious Shortage Protocol in force; 1 expired on this record (below)
Scotlandno NHS Scotland alert matched to this name (separate record)

Presentations, as stated in the latest recorded notice

Each line is re-expressed from MSN/2021/071 (22 Dec 2021): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.

PresentationStatus, as statedExpected back, as statedStated in
Conjugated oestrogens/ medroxyprogesterone (Premique Low Dose®) 300microgram/1.5mg modified-release tabletsaffected product · inferred from phrasing · its own page →Out of stock, as statedw/c 10th January 2022precision: a month · window end 16 Jan 2022, derived from “w/c 10th January 2022”notice of 22 Dec 2021
Alternative continuous combined oestrogen and progesterone tabletsclass-level statement by the source, not a named product · inferred from phrasingStated as available— not stated for this linenotice of 22 Dec 2021

Protocol in force

No Serious Shortage Protocol matched to this name is in force on the NHSBSA register — 1 earlier protocol on this record has expired: SSP021 (to 29 Jul 2022). Matching is by name until identifier coding lands.

Named in the source as remaining available

The latest recorded notice names no alternative as remaining available.

Identifiers — Premique Low Dose

Also known as
Premique Low Dose 0.3mg/1.5mg modified-release tablets
BNF chemical
Oestrogens conjugated with progestogen 0604011Q0 — matched on a brand name
Class
Female sex hormones and their modulators · Sex Hormones · Endocrine System
SNOMED codes
7340311000001105
Suppliers named in the NHSBSA dataset
Pfizer Ltd (from the dataset, not from the notices)
Also recorded under
Conjugated Oestrogens — same BNF chemical; separate pages, separate counts

BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.

BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.

History

One supply notification on record, 22 Dec 2021. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.

IssuedNoticeKindTierReference
22 Dec 2021Medicine Supply Notification: Premique Low Dose® tabsSupply notificationTier 2MSN/2021/071

Also recorded under

No other name appears in this medicine's notice titles. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.

Scotland — separate record

No NHS Scotland Medicine Supply Alert Notice on record matches this name. Scotland is a separate record (all Scotland alerts); absence here is not a statement about supply in Scotland.

Last checked
20 Oct 2026 — sources are checked twice daily by scheduled jobs, not continuously
Last source change
19 Oct 2026
Latest notice captured
21 May 2024
Sources
Latest notice post ↗https://cpe.org.uk/our-news/medicine-supply-notification-conjugated-oestrogens-medroxyprogesterone-premique-low-dose-300microgram-1-5mg-modified-release-tablets · methodology · corrections log

Re-expressed facts with links to the source documents; roles are inferred from phrasing and flagged; fuzzy dates stay fuzzy. Not an official NHS or DHSC service and not clinical advice — in a shortage, follow the guidance issued to your pharmacy or prescriber. Absence of a record is never availability.